According to a small UK study, patients with Crohn’s disease who had exclusive enteral nutrition before undergoing elective intestinal surgery have lower risks of postoperative abscess or intestinal leakage. [Aliment Pharmacol Ther 2017;45(5):660–669]
A recent study presented at the European Cancer Congress 2017 (ECCO 2017) in Amsterdam, the Netherlands, shows promise with a breath test measuring five chemicals in the detection of possible gastric and oesophageal cancers.
The improvement in overall survival (OS) among individuals given a combination of gemcitabine and capecitabine as adjuvant chemotherapy after surgically resected pancreatic adenocarcinoma highlights a potential new standard of care, according to findings of the phase III, open-label, multicentre ESPAC-4* trial.
Bezlotoxumab, a human monoclonal antibody against Clostridium difficile (C. difficile) toxin B, appears to reduce the risk of recurrent C. difficile infection, according to findings from the MODIFY I* and MODIFY II** trials.
Simultaneous BRAF and EGFR inhibition in patients with metastatic colorectal cancer (mCRC) harbouring BRAFV600 mutations is shown to be effective in a recent randomized study.
Long-term use of low-dose aspirin reduces the risk of colorectal cancer (CRC) mortality at the expense of increased gastrointestinal (GI) bleeding–related deaths.